EditorialEditorial
Hydroxychloroquine — How Much Is Too Much?
VANEET KAUR SANDHU and MICHAEL H. WEISMAN
The Journal of Rheumatology April 2019, 46 (4) 340-342; DOI: https://doi.org/10.3899/jrheum.180639
VANEET KAUR SANDHU
Division of Rheumatology, Department of Medicine, Loma Linda University, Loma Linda, California;
MDRoles: Assistant Professor of Medicine, Associate Program Director
MICHAEL H. WEISMAN
Cedars Sinai Medical Center, Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California,
USA.
MDRoles: Emeritus Professor of Medicine
REFERENCES
- 1.↵
- Jaramillo-Arango JA
- 2.↵
- Delepine M
- 3.↵
- 4.↵
- Goodman LS,
- Gilman A
- 5.↵
- 6.↵
- World Health Organization
- 6a.↵
- Tselios K,
- Deeb M,
- Gladman DD,
- Harvey P,
- Akhtari S,
- Mak S,
- et al.
- 7.↵
- Tselios K,
- Deeb M,
- Gladman DD,
- Harvey P,
- Urowitz MB
- 8.↵
- Ritschel WA,
- Kearns GL
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- Baguet JP,
- Tremel F,
- Fabre M
- 19.↵
In this issue
The Journal of Rheumatology
Vol. 46, Issue 4
1 Apr 2019
Hydroxychloroquine — How Much Is Too Much?
VANEET KAUR SANDHU, MICHAEL H. WEISMAN
The Journal of Rheumatology Apr 2019, 46 (4) 340-342; DOI: 10.3899/jrheum.180639